Alterations of plasma endocannabinoid levels in MCI and dementia patients

Daman Kaur, David Finn (Editor), Magda Bucholc (Editor), Stephen Todd (Editor), KongFatt Wong-Lin (Editor), Paula McClean (Editor)

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

There is growing evidence that alterations in the endocannabinoid system (ECS) co-occur with dementia pathophysiology. Currently, limited literature is available on components of the peripheral ECS as diagnostic markers for dementia.In the present study we analysed the concentrations of the endocannabinoids (eCBs) anandamide (AEA) and 2-Arachidonoylglycerol (2-AG), and their lipid congeners N-palmitoylethanolamide (PEA) and N-oleoylethanolamide (OEA) in plasma and serum using LC-MS/MS. Samples were collected from healthy controls, participants with mild cognitive impairment (MCI), Alzheimer’s disease (AD) and other dementia subtypes (OD).Statistical analysis revealed significantly lower concentrations of plasma AEA (p: 0.0017), PEA (p: 0.0056) and OEA (p: 0.0015) in MCI vs. OD groups, and lower OEA levels in MCI vs. healthy controls (p: 0.0099). Plasma PEA levels in AD patients were lower compared to healthy controls (p: 0.0409) and OD groups (p: 0.0307). Additionally, plasma 2-AG levels correlated positively with age and body mass index (p<0.0001), and negatively with ACE-III scores (p<0.0011).These results suggest that peripheral levels of eCBs vary with age and cognitive decline, and may be beneficial in differential diagnosis of dementia. Further, plasma eCB levels may be indicative of early stages of cognitive impairment like MCI, which currently is difficult to diagnose.
Original languageEnglish
Title of host publicationAAIC Neuroscience Next 2021
Publication statusPublished - 12 Oct 2021
EventAlzheimer's Association International Conference Neuroscience Next -
Duration: 12 Oct 2021 → …

Conference

ConferenceAlzheimer's Association International Conference Neuroscience Next
Period12/10/21 → …

Fingerprint

Dive into the research topics of 'Alterations of plasma endocannabinoid levels in MCI and dementia patients'. Together they form a unique fingerprint.

Cite this